Zhu S, Hao Z, Chen Q, Liu X, Wu W, Zhang F
Front Endocrinol (Lausanne). 2025; 15:1369800.
PMID: 39911233
PMC: 11794073.
DOI: 10.3389/fendo.2024.1369800.
Takhvar A, Akbari S, Souri E, Ahmadkhaniha R, Morsali A, Khoshayand M
Daru. 2024; 32(2):617-630.
PMID: 39136927
PMC: 11555170.
DOI: 10.1007/s40199-024-00531-0.
Li S, Hu G, Chen Y, Sang Y, Tang Q, Liu R
Cancer Cell Int. 2024; 24(1):271.
PMID: 39097722
PMC: 11297792.
DOI: 10.1186/s12935-024-03459-2.
Flynn A, Pattison A, Balachander S, Boehm E, Bowen B, Dwight T
Res Sq. 2024; .
PMID: 38978571
PMC: 11230496.
DOI: 10.21203/rs.3.rs-4410500/v1.
Wang F, McCulloh D, Chan K, Wiltshire A, McCaffrey C, Grifo J
Genes (Basel). 2023; 14(6).
PMID: 37372380
PMC: 10298191.
DOI: 10.3390/genes14061200.
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia.
da Mota T, Camargo R, Biojone E, Guimaraes A, Pittella-Silva F, de Oliveira D
Genes (Basel). 2023; 14(3).
PMID: 36980962
PMC: 10048576.
DOI: 10.3390/genes14030691.
Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis.
Gonzalez-Moles M, Moya-Gonzalez E, Garcia-Ferrera A, Nieto-Casado P, Ramos-Garcia P
Cancers (Basel). 2022; 14(15).
PMID: 35954336
PMC: 9367569.
DOI: 10.3390/cancers14153673.
A subset of gut leukocytes has telomerase-dependent "hyper-long" telomeres and require telomerase for function in zebrafish.
Ellis P, Martins R, Thompson E, Farhat A, Renshaw S, Henriques C
Immun Ageing. 2022; 19(1):31.
PMID: 35820929
PMC: 9277892.
DOI: 10.1186/s12979-022-00287-8.
Telomerase in Cancer: Function, Regulation, and Clinical Translation.
Robinson N, Schiemann W
Cancers (Basel). 2022; 14(3).
PMID: 35159075
PMC: 8834434.
DOI: 10.3390/cancers14030808.
Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction.
Sharma S, Mukherjee A, Roy S, Bagri S, Lier S, Verma M
Cell Rep. 2021; 35(7):109154.
PMID: 34010660
PMC: 7611063.
DOI: 10.1016/j.celrep.2021.109154.
Therapeutic targeting of FOS in mutant cancers through removing TERT suppression of apoptosis via regulating and .
Liu R, Tan J, Shen X, Jiang K, Wang C, Zhu G
Proc Natl Acad Sci U S A. 2021; 118(11).
PMID: 33836600
PMC: 7980366.
DOI: 10.1073/pnas.2022779118.
Cancer-specific loss of activation sensitizes glioblastoma to DNA damage.
Amen A, Fellmann C, Soczek K, Ren S, Lew R, Knott G
Proc Natl Acad Sci U S A. 2021; 118(13).
PMID: 33758097
PMC: 8020668.
DOI: 10.1073/pnas.2008772118.
The Connection Between Cell Fate and Telomere.
Engin A, Engin A
Adv Exp Med Biol. 2021; 1275:71-100.
PMID: 33539012
DOI: 10.1007/978-3-030-49844-3_3.
Are long telomeres better than short? Relative contributions of genetically predicted telomere length to neoplastic and non-neoplastic disease risk and population health burden.
Protsenko E, Rehkopf D, Prather A, Epel E, Lin J
PLoS One. 2020; 15(10):e0240185.
PMID: 33031470
PMC: 7544094.
DOI: 10.1371/journal.pone.0240185.
TERT mutations correlate with higher TMB value and unique tumor microenvironment and may be a potential biomarker for anti-CTLA4 treatment.
Li H, Li J, Zhang C, Zhang C, Wang H
Cancer Med. 2020; 9(19):7151-7160.
PMID: 32810393
PMC: 7541140.
DOI: 10.1002/cam4.3376.
Telomerase Biogenesis and Activities from the Perspective of Its Direct Interacting Partners.
Nguyen K, Wong J
Cancers (Basel). 2020; 12(6).
PMID: 32599885
PMC: 7352425.
DOI: 10.3390/cancers12061679.
Telomerase promotes formation of a telomere protective complex in cancer cells.
Perera O, Sobinoff A, Teber E, Harman A, Maritz M, Yang S
Sci Adv. 2019; 5(10):eaav4409.
PMID: 31616780
PMC: 6774720.
DOI: 10.1126/sciadv.aav4409.
Human T Cell Differentiation Negatively Regulates Telomerase Expression Resulting in Reduced Activation-Induced Proliferation and Survival.
Patrick M, Cheng N, Kim J, An J, Dong F, Yang Q
Front Immunol. 2019; 10:1993.
PMID: 31497023
PMC: 6712505.
DOI: 10.3389/fimmu.2019.01993.
PES1 is a critical component of telomerase assembly and regulates cellular senescence.
Cheng L, Yuan B, Ying S, Niu C, Mai H, Guan X
Sci Adv. 2019; 5(5):eaav1090.
PMID: 31106266
PMC: 6520020.
DOI: 10.1126/sciadv.aav1090.
In perspective: An update on telomere targeting in cancer.
Sugarman E, Zhang G, Shay J
Mol Carcinog. 2019; 58(9):1581-1588.
PMID: 31062416
PMC: 6692182.
DOI: 10.1002/mc.23035.